Australia markets open in 1 hour 45 minutes

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0900-0.0020 (-2.17%)
At close: 04:10PM AEST

ImpediMed Limited

50 Parker Court
Unit 1
Pinkenba, QLD 4008
61 7 3860 3700

Sector(s):Β Healthcare
Industry:Β Medical Devices
Full-time employees:Β 73

Key executives

NameTitlePayExercisedYear born
Mr. Richard CarreonMD, CEO, Pres & Exec. Director1.36MN/AN/A
Mr. Timothy CruickshankChief Financial Officer562.65kN/AN/A
Mr. David Michae Adams B.Sc., J.D., BScSr. VP of Operations & Strategic Planning586.29kN/AN/A
Mr. Shashi TripathiChief Technology Officer592.16kN/AN/A
Mr. Dennis SchlahtSr. VP of R&D and Technology637.47kN/AN/A
Ms. Catherine KingsfordSr. VP of Medical Affairs500.53kN/AN/A
Mr. Michael John BassettSr. VP of Corp. & Strategic Devel.N/AN/AN/A
Ms. Nancy T. DeisingerVP of HRN/AN/AN/A
Dr. Frank A. Vicini FACR, M.D.Chief Medical OfficerN/AN/AN/A
Ms. Leanne Ralph AAICD, ACIS, BBusCompany Sec.N/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Corporate governance

ImpediMed Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.